AR and nonpapillary renal cell carcinoma: Similar to previously described reports, we found that the expression of AR-FL and all the SVs, except AR-V12, differed between ccRCC tumors of different pT stages with pT1 tumors showing the highest expression and pT4 tumors showing the lowest expression.